1. Neuroscience
Download icon

Presynaptic GABAB receptors functionally uncouple somatostatin interneurons from the active hippocampal network

  1. Sam A Booker  Is a corresponding author
  2. Harumi Harada
  3. Claudio Elgueta
  4. Julia Bank
  5. Marlene Bartos
  6. Akos Kulik  Is a corresponding author
  7. Imre Vida  Is a corresponding author
  1. University of Edinburgh, United Kingdom
  2. University of Freiburg, Germany
  3. Charité - Universitätsmedizin Berlin, Germany
Research Article
  • Cited 0
  • Views 1,027
  • Annotations
Cite this article as: eLife 2020;9:e51156 doi: 10.7554/eLife.51156

Abstract

Information processing in cortical neuronal networks relies on properly balanced excitatory and inhibitory neurotransmission. A ubiquitous motif for maintaining this balance is the somatostatin interneuron (SOM-IN) feedback microcircuit. Here, we investigate the modulation of this microcircuit by presynaptic GABAB receptors (GABABRs) in the rodent hippocampus. Whole-cell recordings from SOM-INs revealed that both excitatory and inhibitory synaptic inputs are strongly inhibited by GABABRs, while optogenetic activation of the interneurons shows that their inhibitory output is also strongly suppressed. Electron microscopic analysis of immunogold-labelled freeze-fracture replicas confirms that GABABRs are highly expressed presynaptically at both input and output synapses of SOM-INs. Activation of GABABRs selectively suppresses the recruitment of SOM-INs during gamma oscillations induced in vitro. Thus, axonal GABABRs are positioned to efficiently control the input and output synapses of SOM-INs and can functionally uncouple them from local network with implications for rhythmogenesis and the balance of entorhinal versus intrahippocampal afferents.

Article and author information

Author details

  1. Sam A Booker

    Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom
    For correspondence
    sbooker@exseed.ed.ac.uk
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-1980-9873
  2. Harumi Harada

    Institute of Physiology, University of Freiburg, Freiburg, Germany
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-7429-7896
  3. Claudio Elgueta

    Institute for Physiology I, University of Freiburg, Freiburg, Germany
    Competing interests
    No competing interests declared.
  4. Julia Bank

    Institute of Physiology, University of Freiburg, Freiburg, Germany
    Competing interests
    No competing interests declared.
  5. Marlene Bartos

    Institute for Physiology I, University of Freiburg, Freiburg, Germany
    Competing interests
    Marlene Bartos, Reviewing editor, eLife.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9741-1946
  6. Akos Kulik

    Institute of Physiology, University of Freiburg, Freiburg, Germany
    For correspondence
    akos.kulik@physiologie.uni-freiburg.de
    Competing interests
    No competing interests declared.
  7. Imre Vida

    Institute for Integrative Neuroanatomy, Charité - Universitätsmedizin Berlin, Berlin, Germany
    For correspondence
    imre.vida@charite.de
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-3214-2233

Funding

Deutsche Forschungsgemeinschaft (FOR 2134)

  • Marlene Bartos
  • Akos Kulik
  • Imre Vida

Deutsche Forschungsgemeinschaft (BIOSS-2)

  • Akos Kulik

Tenovus

  • Imre Vida

McNaught Bequest, University of Glasgow

  • Sam A Booker
  • Imre Vida

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: Care and handling of the animals prior to and during the experimental procedures followed European Union and national regulations (German Animal Welfare Act; ASPA, United Kingdom Home Office) and all experiments were performed in accordance with institutional guidelines (Charité - Universitätmedizin Berlin; University of Freiburg, Freiburg, Germany), with permissions from local authorities (LaGeSo, Berlin, T-0215/11 LaGeSo; Freiburg, X14/11H and 35-9185.81/G-19/59).

Reviewing Editor

  1. John Huguenard, Stanford University School of Medicine, United States

Publication history

  1. Received: August 16, 2019
  2. Accepted: February 18, 2020
  3. Accepted Manuscript published: February 19, 2020 (version 1)
  4. Version of Record published: March 6, 2020 (version 2)

Copyright

© 2020, Booker et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,027
    Page views
  • 228
    Downloads
  • 0
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Download citations (links to download the citations from this article in formats compatible with various reference manager tools)

Open citations (links to open the citations from this article in various online reference manager services)

Further reading

    1. Neuroscience
    Amy A Worth et al.
    Research Article Updated

    The cytokine, GDF15, is produced in pathological states which cause cellular stress, including cancer. When over expressed, it causes dramatic weight reduction, suggesting a role in disease-related anorexia. Here, we demonstrate that the GDF15 receptor, GFRAL, is located in a subset of cholecystokinin neurons which span the area postrema and the nucleus of the tractus solitarius of the mouse. GDF15 activates GFRALAP/NTS neurons and supports conditioned taste and place aversions, while the anorexia it causes can be blocked by a monoclonal antibody directed at GFRAL or by disrupting CCK neuronal signalling. The cancer-therapeutic drug, cisplatin, induces the release of GDF15 and activates GFRALAP/NTS neurons, as well as causing significant reductions in food intake and body weight in mice. These metabolic effects of cisplatin are abolished by pre-treatment with the GFRAL monoclonal antibody. Our results suggest that GFRAL neutralising antibodies or antagonists may provide a co-treatment opportunity for patients undergoing chemotherapy.

    1. Neuroscience
    Jessica M Jones et al.
    Tools and Resources

    Objective and automatic measurement of pain in mice remains a barrier for discovery in neuroscience. Here we capture paw kinematics during pain behavior in mice with high-speed videography and automated paw tracking with machine and deep learning approaches. Our statistical software platform, PAWS (Pain Assessment at Withdrawal Speeds), uses a univariate projection of paw position over time to automatically quantify seven behavioral features that are combined into a single, univariate pain score. Automated paw tracking combined with PAWS reveals a behaviorally-divergent mouse strain that displays hyper-sensitivity to mechanical stimuli. To demonstrate the efficacy of PAWS for detecting spinally- versus centrally-mediated behavioral responses, we chemogenetically activated nociceptive neurons in the amygdala, which further separated the pain-related behavioral features and the resulting pain score. Taken together, this automated pain quantification approach will increase objectivity in collecting rigorous behavioral data, and it is compatible with other neural circuit dissection tools for determining the mouse pain state.